Disease analysis Archives | Report Store

show blocks helper

Sort by Default Order
- Default Order
- Name
- Price
- Date
- Popularity

Click to order products descending

Display 15 Products per page

Schizophrenia Disease Coverage to 2024
Read More
Schizophrenia is a serious mental illness, characterized by incoherent or illogical thoughts, bizarre behavior and speech, and delusions or hallucinations, such as hearing voices.
July 31, 2019
Find out more
Epilepsy Forecast and Market Analysis to 2035
Read More
Epilepsy is characterized by recurrent, unprovoked seizures. A seizure occurs when the normal pattern of neuronal activity is disturbed, defined by the National Institute of Neurological Disorders and Stroke as causing “strange sensations, emotions, and behavior or sometimes convulsions, muscle spasms, and loss of consciousness.”
July 26, 2019
Find out more
Non-alcoholic steatohepatitis (NASH) Market and Forecast Analysis to 2038
Read More
Non-alcoholic fatty liver disease (NAFLD) is a hepatic condition closely associated with metabolic syndrome, and non-alcoholic steatohepatitis (NASH) is a segment of NAFLD. Both NAFLD and NASH patients display hepatic steatosis, and do not drink more than recommended guideline amounts of alcohol.
July 22, 2019
Find out more
HIV Disease Coverage Forecast and Market Analysis to 2027
Read More
The human immunodeficiency virus, or HIV, is a retrovirus that infects the cells of the immune system such as T lymphocytes, specifically cluster of differentiation-4+ T cells, dendritic cells, and macrophages.
June 28, 2019
Find out more
Prostate Cancer Disease Coverage Forecast and Market Analysis to 2024
Read More
Prostate cancer is a hormonally fueled disease, and the most common form of cancer found in males. Consequently, there is a high incentive for drug development in this indication due to its large population size.
June 1, 2019
Find out more
Depression Disease Market and Forecast Analysis 2024
Read More
Novel drugs, including Johnson & Johnson’s Spravato and SAGE Therapeutics’ Zulresso, will propel impressive expansion, more than doubling the size of the #depression market from 2017-26.

Discover the prevailing trends and changing landscape of the depression market in this report from Datamonitor Healthcare.
March 29, 2019
Find out more
Chronic Heart Failure Market and Forecast Analysis to 2024
Read More
The chronic heart failure (CHF) market is expected to grow significantly following increased use of Entresto and the launch of pipeline therapies. Discover how the CHF market will change over the next 10 years in this report from Datamonitor Healthcare.
March 21, 2019
Find out more
Renal cell cancer (RCC) disease forecast and market analysis to 2038
Read More
Renal cell cancer (RCC) is a tumor that originates in the renal cortex, the outer part of the kidney between the renal capsule and the renal medulla. Around 85% of all malignant kidney tumors are RCC, with other types including transitional cell carcinoma of the renal pelvis and Wilms’ tumor (nephroblastoma).
March 6, 2019
Find out more
Multiple Myeloma Disease Coverage Forecast and Market Analysis to 2024
Read More
Multiple myeloma is characterized by the infiltration of malignant, antibody-producing plasma cells in the bone marrow.
March 5, 2019
Find out more
Diabetic Nephropathy Market and Forecast Analysis to 2037
Read More
Diabetic nephropathy, also known as diabetic kidney disease, is caused by damage to small blood vessels which can cause the kidneys to be less efficient in their blood filtration role or to fail altogether.
February 27, 2019
Find out more
Alzheimer’s Disease Market and Forecast Analysis 2034
Read More
Alzheimer’s disease is an irreversible, progressive, neurodegenerative, and fatal disease that slowly affects memory, cognition, and function.
February 25, 2019
Find out more
Hepatocellular Cancer Disease Coverage Forecast and Market Analysis to 2035
Read More
Malignant tumors of the liver are primarily adenocarcinomas, with two major cell types: hepatocellular carcinoma (ie hepatocellular cancer), and cholangiocarcinoma.
February 20, 2019
Find out more
Chronic Lymphocytic Leukemia (CLL)
Read More
Chronic lymphocytic leukemia (CLL) is a disease characterized by an accumulation of mature malignant B lymphocytes in the peripheral blood, bone marrow, and lymph nodes.
January 31, 2019
Find out more
NHL: Follicular Lymphoma Forecast and Market Analysis (FL) to 2026
Read More
Follicular lymphoma (FL) is an indolent subtype of non-Hodgkin’s lymphoma (NHL). It is the second most common type of NHL after diffuse large B-cell lymphoma (DLBCL), and accounts for more than 20% of all NHL cases.
January 30, 2019
Find out more
Chronic Obstructive Pulmonary Disease Forecast and Market Analysis to 2026
Read More
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. In 2004, it was the fourth most common cause of death in the world.
January 22, 2019
Find out more

Disease analysis

Disease analysis

Schizophrenia Disease Coverage to 2024

Epilepsy Forecast and Market Analysis to 2035

Non-alcoholic steatohepatitis (NASH) Market and Forecast Analysis to 2038

HIV Disease Coverage Forecast and Market Analysis to 2027

Prostate Cancer Disease Coverage Forecast and Market Analysis to 2024

Depression Disease Market and Forecast Analysis 2024

Chronic Heart Failure Market and Forecast Analysis to 2024

Renal cell cancer (RCC) disease forecast and market analysis to 2038

Multiple Myeloma Disease Coverage Forecast and Market Analysis to 2024

Diabetic Nephropathy Market and Forecast Analysis to 2037

Alzheimer’s Disease Market and Forecast Analysis 2034

Hepatocellular Cancer Disease Coverage Forecast and Market Analysis to 2035

Chronic Lymphocytic Leukemia (CLL)

NHL: Follicular Lymphoma Forecast and Market Analysis (FL) to 2026

Chronic Obstructive Pulmonary Disease Forecast and Market Analysis to 2026